18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT

Clinical Nuclear Medicine

Volumn 40, Issue 8, 2015, Pages e386-e391

  Nanni, Cristina ^a   Schiavina, Riccardo ^b   Brunocilla, Eugenio ^b   Boschi, Stefano ^a   Borghesi, Marco ^b   Zanoni, Lucia ^b   Pettinato, Cinzia ^a   Martorana, Giuseppe ^b   Fanti, Stefano ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b OU Urology   (Italy)

Author keywords

11C choline; Anti 3 18F FACBC; fluciclovine; PET CT; prostate cancer; PSA

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CHOLINE C 11; FLUCICLOVINE F 18; PROSTATE SPECIFIC ANTIGEN; 1-AMINO-3-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; CARBON; CARBOXYLIC ACID; CHOLINE; CYCLOBUTANE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE LESION; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCINTISCANNING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLEASON SCORE; HUMAN; IMAGE RECONSTRUCTION; MALE; MULTIMODALITY CANCER THERAPY; PET-CT SCANNER; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; THREE DIMENSIONAL IMAGING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; SCINTISCANNING; TUMOR RECURRENCE;

AGED; CARBON RADIOISOTOPES; CARBOXYLIC ACIDS; CHOLINE; CYCLOBUTANES; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84938059506     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000849     Document Type: Article

References (19)

1. Pfitzenmaier J, Pahernik S, Tremmel T, et al. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int. 2008;102:1413-1418.
2. RouvièreO. Imaging techniques for local recurrence of prostate cancer: forwhom, why and how? Diagn Interv Imaging. 2012;93:279-290.
3. Krause BJ, Souvatzoglou M, Tuncel M, et al. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patientswith biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:18-23.
4. Oka S, Okudaira H, Yoshida Y, et al. Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C] cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol. 2012;39:109-119.
5. SchusterDM, Votaw JR, Nieh PT, et al. Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma. J NuclMed. 2007;48:56-63.
6. Sörensen J, Owenius R, Lax M, et al. Regional distribution and kinetics of [18F] fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2013;40:394-402.
7. Schuster DM, Savir-Baruch D, Nieh P, et al. Detection of recurrent prostate carcinoma with anti-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111Incapromab pendetide SPECT/CT. Radiology. 2011;259:852-861.
8. Nanni C, Schiavina R, Boschi S, et al. Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results. Eur J Nucl Med Mol Imaging. 2013; 40(Suppl 1):S11-S17.
9. Nanni C, Schiavina R, Brunocilla E, et al. 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients. Clin Genitourin Cancer. 2014;12:106-110.
10. McConathy J, Voll RJ, Yu W, et al. Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis. Appl Radiat Isot. 2003;58:657-666.
11. Pascali C, Bogni A, Itawa R, et al. [11C]Methylation on a C18 Sep-Pak cartridge: a convenient way to produce N-methyl-11C-choline. J LabelledCompRadiopharm. 2000;49:195-203.
12. IatrouM, Ross SG, Manjeshwar RM, et al. A fully 3D iterative image reconstruction algorithm incorporating data corrections. IEEE Nucl Sci Symp Conf Rec. 2004;4:2493-2497.
13. Choueiri TK, Dreicer R, Paciorek A, et al. A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy. J Urol. 2008;179:906-910.
14. Martorana G, Schiavina R, Corti B, et al. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol. 2006;176:954-960.
15. Fuccio C, Castellucci P, Schiavina R, et al. Role of 11C-choline PET/CT in the restaging of prostate cancer patientswith biochemical relapse and negative results at bone scintigraphy. Eur J Radiol. 2012;81:e893-e896.
16. Nye JA, Schuster DM, YuW, et al. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. J NuclMed. 2007;48:1017-1020.
17. Tolvanen T, Yli-Kerttula T, Ujula T, et al. Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data. Eur J Nucl Med Mol Imaging. 2010;37:874-883.
18. Turkbey B, Mena E, Shih J, et al. Localized prostate cancer detection with 18F FACBC PET/CT: comparison withMR imaging and histopathologic analysis. Radiology. 2014;270:849-856.
19. Farsad M, Schiavina R, Castellucci P, et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J NuclMed. 2005;46:1642-1649.